Ipca Laboratories has received the US Food and Drug Administration (USFDA) approval for its oral solid dosage formulations manufacturing facility situated at Pharmazone, SEZ Indore, Pithampur in Madhya Pradesh. This approval will enable the company to commercialize more oral solid dosage formulations in the US market.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
